Concepedia

Mary-Beth H Moore

MH

Statistics

Publications

3

Citations

554

H-Index

3

Active since

1999

Affiliations

Amplimmune (United States)(Current)

Mary-Beth H Moore is an author at Amplimmune (United States) specializing in lung cancer, oncology, and medicine.

Top concepts

Publications per year

1999–2003

3

Publications

3

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

Michael S. Kinch, Mary-Beth H Moore, David H. Harpole · PubMed · 2003 · 239 citations

, , +14

A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers

Thomas A. D’Amico, Marga F. Massey, James E. Herndon et al. · Journal of Thoracic and Cardiovascular Surgery · 1999 · 233 citations · Full text

, , +11

Predicting the sites of metastases from lung cancer using molecular biologic markers

Thomas A. D’Amico, Thomas A. Aloia, Mary-Beth H Moore et al. · The Annals of Thoracic Surgery · 2001 · 82 citations

, , +10

1–3 of 3